Screening for cytomegalovirus antibody in a donor insemination program: difficulties in implementing The American Fertility Society guidelines

Mayursingh Chauhan; Christopher L. R. Barratt; Sheila Cooke; Ian D. Cooke

doi:10.1016/S0015-0282(16)60689-1

Screening for cytomegalovirus antibody in a donor insemination program: difficulties in implementing The American Fertility Society guidelines

Mayursingh Chauhan, Christopher L. R. Barratt (Lead / Corresponding author), Sheila Cooke, Ian D. Cooke

Undergraduate Medicine

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

With the recommendations of The American Fertility Society that all donors and recipients in a donor insemination programme should be screened for CMV antibody, we have documented the prevalence of CMV antibody in donors, recipients, and their partners in our clinic. Forty percent of our donors were CMV-positive, and in only 35% of the couples were both partners negative. The implications of using exclusively CMV-negative donors are examined. The necessity for further research on the detection and the transmission of various strains of CMV and the effects of cryopreservation on them is emphasized.

Original language	English
Pages (from-to)	901-2
Number of pages	2
Journal	Fertility and Sterility
Volume	51
Issue number	5
DOIs	https://doi.org/10.1016/S0015-0282(16)60689-1
Publication status	Published - May 1989

Keywords

Antibodies, Viral/analysis
Complement Fixation Tests
Cytomegalovirus/immunology
Female
Fertility
Health Planning
Health Planning Guidelines
Humans
Insemination, Artificial
Latex Fixation Tests
Male
Societies, Medical

Access to Document

10.1016/S0015-0282(16)60689-1Licence: No Licence / Unknown

Cite this

@article{3ac68b74c8d6451ca020cadc25d18e14,

title = "Screening for cytomegalovirus antibody in a donor insemination program: difficulties in implementing The American Fertility Society guidelines",

abstract = "With the recommendations of The American Fertility Society that all donors and recipients in a donor insemination programme should be screened for CMV antibody, we have documented the prevalence of CMV antibody in donors, recipients, and their partners in our clinic. Forty percent of our donors were CMV-positive, and in only 35% of the couples were both partners negative. The implications of using exclusively CMV-negative donors are examined. The necessity for further research on the detection and the transmission of various strains of CMV and the effects of cryopreservation on them is emphasized.",

keywords = "Antibodies, Viral/analysis, Complement Fixation Tests, Cytomegalovirus/immunology, Female, Fertility, Health Planning, Health Planning Guidelines, Humans, Insemination, Artificial, Latex Fixation Tests, Male, Societies, Medical",

author = "Mayursingh Chauhan and Barratt, {Christopher L. R.} and Sheila Cooke and Cooke, {Ian D.}",

year = "1989",

month = may,

doi = "10.1016/S0015-0282(16)60689-1",

language = "English",

volume = "51",

pages = "901--2",

journal = "Fertility and Sterility",

issn = "0015-0282",

publisher = "Elsevier",

number = "5",

}

Screening for cytomegalovirus antibody in a donor insemination program: difficulties in implementing The American Fertility Society guidelines. / Chauhan, Mayursingh; Barratt, Christopher L. R. (Lead / Corresponding author); Cooke, Sheila et al.
In: Fertility and Sterility, Vol. 51, No. 5, 05.1989, p. 901-2.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Screening for cytomegalovirus antibody in a donor insemination program

T2 - difficulties in implementing The American Fertility Society guidelines

AU - Chauhan, Mayursingh

AU - Barratt, Christopher L. R.

AU - Cooke, Sheila

AU - Cooke, Ian D.

PY - 1989/5

Y1 - 1989/5

N2 - With the recommendations of The American Fertility Society that all donors and recipients in a donor insemination programme should be screened for CMV antibody, we have documented the prevalence of CMV antibody in donors, recipients, and their partners in our clinic. Forty percent of our donors were CMV-positive, and in only 35% of the couples were both partners negative. The implications of using exclusively CMV-negative donors are examined. The necessity for further research on the detection and the transmission of various strains of CMV and the effects of cryopreservation on them is emphasized.

AB - With the recommendations of The American Fertility Society that all donors and recipients in a donor insemination programme should be screened for CMV antibody, we have documented the prevalence of CMV antibody in donors, recipients, and their partners in our clinic. Forty percent of our donors were CMV-positive, and in only 35% of the couples were both partners negative. The implications of using exclusively CMV-negative donors are examined. The necessity for further research on the detection and the transmission of various strains of CMV and the effects of cryopreservation on them is emphasized.

KW - Antibodies, Viral/analysis

KW - Complement Fixation Tests

KW - Cytomegalovirus/immunology

KW - Female

KW - Fertility

KW - Health Planning

KW - Health Planning Guidelines

KW - Humans

KW - Insemination, Artificial

KW - Latex Fixation Tests

KW - Male

KW - Societies, Medical

U2 - 10.1016/S0015-0282(16)60689-1

DO - 10.1016/S0015-0282(16)60689-1

M3 - Article

C2 - 2540049

SN - 0015-0282

VL - 51

SP - 901

EP - 902

JO - Fertility and Sterility

JF - Fertility and Sterility

IS - 5

ER -

Screening for cytomegalovirus antibody in a donor insemination program: difficulties in implementing The American Fertility Society guidelines

Abstract

Keywords

Access to Document

Fingerprint

Cite this